Ankylosing spondylitis and Bone density decreased

Summary:

Bone density decreased is found among people with Ankylosing spondylitis, especially for people who are female, 40-49 old.

The study analyzes which people have Bone density decreased with Ankylosing spondylitis. It is created by eHealthMe based on reports of 57 people who have Ankylosing spondylitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Ankylosing spondylitis?

Ankylosing spondylitis (type of arthritis affecting the spine) is found to be associated with 746 drugs and 1,048 conditions by eHealthMe. Check the latest studies of Ankylosing spondylitis.

What is Bone density decreased?

Bone density decreased is found to be associated with 1,126 drugs and 945 conditions by eHealthMe. Check the latest studies of Bone density decreased.



On Jul, 19, 2026

57 people who have Ankylosing Spondylitis and Bone Density Decreased are studied.

Would you have Bone density decreased when you have Ankylosing spondylitis?

Gender of people who have Ankylosing Spondylitis and experienced Bone Density Decreased *:

  • female: 63.64 %
  • male: 36.36 %

Age of people who have Ankylosing Spondylitis and experienced Bone Density Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 10 %
  • 40-49: 44 %
  • 50-59: 28 %
  • 60+: 18 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 11 people, 19.30%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 14.04%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 6 people, 10.53%
  4. High Blood Cholesterol: 4 people, 7.02%
  5. Pain: 4 people, 7.02%
  6. Swelling: 4 people, 7.02%
  7. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 5.26%
  8. Inflammation: 3 people, 5.26%
  9. Heart Disease: 3 people, 5.26%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 5.26%

Common drugs taken by these people *:

  1. Humira: 38 people, 66.67%
  2. Enbrel: 26 people, 45.61%
  3. Celebrex: 25 people, 43.86%
  4. Remicade: 22 people, 38.60%
  5. Cosentyx: 22 people, 38.60%
  6. Simponi: 21 people, 36.84%
  7. Cimzia: 20 people, 35.09%
  8. Aleve: 17 people, 29.82%
  9. Voltaren: 16 people, 28.07%
  10. Folic Acid: 6 people, 10.53%

Common symptoms for these people *:

  1. Drug Ineffective: 27 people, 47.37%
  2. Headache (pain in head): 22 people, 38.60%
  3. Gait Disturbance: 21 people, 36.84%
  4. Joint Pain: 21 people, 36.84%
  5. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 20 people, 35.09%
  6. Inflammation: 20 people, 35.09%
  7. Neuralgia (pain in one or more nerves): 19 people, 33.33%
  8. Feeling Hot: 19 people, 33.33%
  9. Tendonitis (a condition that causes pain and swelling of tendons): 19 people, 33.33%
  10. Back Pain: 15 people, 26.32%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Bone density decreased?

- Check whether Bone density decreased is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Bone density decreased:

All the conditions that are associated with Bone density decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Bone density decreased and Ankylosing spondylitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: